The NORBEN study aims to assess the accuracy and efficacy of a laboratory test using blood specimens from research participants. This study is evaluating an investigational laboratory test and device that aims to detect Non-Hodgkin Lymphoma.
The study is seeking participants who have at least one of a list of specific non-cancerous conditions, diagnosed in the past 5 years to serve as the control group. These categories are designed to test the TEST, to ensure it accurately detects only the biomarker for Non-Hodgkin's Lymphoma and does not get confused by other diseases patients may have.
Criteria:1. Be 18 years of age or older and have been diagnosed with one of the following conditions in the last 5 years:
- Campylobacter jejuni
- Cytomegalovirus (CMV)
- Neisseria gonorrhea (NG)
- Helicobacter pylori (H. Pylori-peptic ulcers)
- Hepatitis B virus (HBV), Hepatitis C virus (HCV)
- Lyme Disease (Borrelia Burgdorferi)
- Epstein-Barr Virus (EBV – infectious mononucleosis aka mono)
- Human Immunodeficiency Virus (HIV)
- Tuberculosis (TB)
- Hyperthyroidism
- Alzheimer’s Disease
- Parkinson’s Disease
- Huntington’s Disease
- Human T-cell lymphotropic virus (HTLV-1/HTLV-2)
- Systemic Lupus Erythematosus (SLE)
- Multiple Sclerosis
- Rheumatoid Arthritis (RA)
- Sjogren’s Disease
- Cirrhosis (from Chronic HBV, HCV- or alcohol use)
- Celiac Disease
- Crohn’s Disease
- Ulcerative colitis
- Coronary Artery Disease
- Cerebral Stroke
- Acute or chronic heart failure
- Myocardial infarction (Heart Attack)
- Meningitis
- Genital Herpes (HSV-2) and other sexually transmitted diseases
2. Be able to provide medical documentation of the diagnosis.
3. Complete a phone pre-screening questionnaire with a study coordinator.
4. Complete a study visit with a blood draw, vital sign measurement, and health history questionnaires.